Albireo to Participate in Jefferies and Piper Sandler Virtual Investor Conferences
BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel...
Year: 2020
Daré Bioscience Reports Third Quarter 2020 Financial Results and Provides Company Update
Conference Call Today at 4:30 p.m. Eastern Time SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE),...
Vaxart Announces Additional Data from Hamster Challenge Study of its Oral COVID-19 Vaccine
Robust Immune Response and Significantly Reduce Viral Load SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc.,...
Tongji Healthcare Group, Inc. Takes First Steps Toward Corporate Name Change and Symbol Change
LOS ANGELES, Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Tongji Healthcare Group, Inc. (OTC Pink: TONJ) ( “Company”)...
Major Teaching Hospital in Massachusetts Acquires XACT ACE™ Robotic System
XACT Robotics® XACT ACE™ Robotic System The first hospital in the U.S. to offer Robotic Percutaneous Radiology Procedures HINGHAM, Mass.,...
MiMedx To Present At Canaccord Genuity Virtual MedTech & Diagnostics Forum
MARIETTA, Ga., Nov. 12, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader...
OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service for Native Specimens and Receives Bulk Order from Public Health Agency
Early access program launched for the next generation of the ARESupa Universal Pathogenome Assay based on targeted next-generation sequencing (NGS)...
Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences
DUBLIN, Ireland and TREVOSE, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on...
Histogen Announces $4.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (Nasdaq: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class therapeutics...
CB Scientific, Inc. (CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC
Acquisition will expand Ambulatory Remote Cardiac ECG Monitoring product technology offering and outreach into US and international markets ESCONDIDO, Calif.,...
Translate Bio to Participate in Upcoming Investor Conferences
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing...
Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress
Recommended Phase 2 Dose and Schedule Selected for Further Evaluation of RMC-4630 as Monotherapy and RMC-4630 plus Cobimetinib Combination First-in-Class...
Apollomics, Inc. Receives China Investigational New Drug Approval for APL-102 to Initiate a Phase 1 Study
FOSTER CITY, Calif. and HANGZHOU, China, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Apollomics, Inc., an innovative biopharmaceutical company committed to...
HOOKIPA Pharma Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
NEW YORK and VIENNA, Austria, Nov. 12, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing...
Protara Therapeutics Announces Third Quarter 2020 Financial Results and Business Overview
- On Track to Complete GMP Batch Runs in Mid-2021 to Confirm Comparability Between TARA-002 and OK-432 -- Expect to Initiate...
Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, an emerging biopharmaceutical company developing Natural Killer Cell Therapeutics, today...
SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights
- Enrollment Complete in the Phase 3 DeFi Trial of Nirogacestat in Adult Patients with Desmoid Tumors - - Clinical...
Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update
Epsolay® PDUFA goal date set for April 26, 2021 Twyneo® New Drug Application submitted to the U.S. FDA Top-line generic...
Correction: Interim report 2020-01-01 to 2020-09-30
Press release (MAR) Malmö, November 12, 2020 Correction: Interim report 2020-01-01 to 2020-09-30 In the interim report that Acarix submitted...
Nabriva Therapeutics to Participate in Upcoming Virtual Investor Conferences
DUBLIN, Ireland, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization...